| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new year, but familiar challenges from COVID-19 in the USA
|
Burki, Talha Khan
|
|
|
9 |
2 |
p. e19
|
artikel
|
| 2 |
Are women with asthma at increased risk for severe COVID-19?
|
Fernando, Mario
|
|
|
9 |
2 |
p. 125-126
|
artikel
|
| 3 |
Aspirin for the primary prevention of sepsis
|
Annane, Djillali
|
|
|
9 |
2 |
p. 121-122
|
artikel
|
| 4 |
Assessing the importance of interleukin-6 in COVID-19
|
Chen, Luke Y C
|
|
|
9 |
2 |
p. e13
|
artikel
|
| 5 |
Assessing the importance of interleukin-6 in COVID-19 – Authors' reply
|
Leisman, Daniel E
|
|
|
9 |
2 |
p. e14-e15
|
artikel
|
| 6 |
Asthma in the anti-inflammatory reliever therapy era
|
Baggott, Christina
|
|
|
9 |
2 |
p. 118-119
|
artikel
|
| 7 |
Caution advised regarding lung recruitment before surfactant
|
Kumar, Vasantha H S
|
|
|
9 |
2 |
p. e11
|
artikel
|
| 8 |
Caution advised regarding lung recruitment before surfactant – Authors’ reply
|
Vento, Giovanni
|
|
|
9 |
2 |
p. e12
|
artikel
|
| 9 |
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?
|
Yarnell, Christopher J
|
|
|
9 |
2 |
p. 207-216
|
artikel
|
| 10 |
Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service
|
Camporota, Luigi
|
|
|
9 |
2 |
p. e16-e17
|
artikel
|
| 11 |
Correction to Lancet Respir Med 2021; 9: 69–84
|
|
|
|
9 |
2 |
p. e18
|
artikel
|
| 12 |
Correction to Lancet Respir Med 2021; 9: 57–68
|
|
|
|
9 |
2 |
p. e18
|
artikel
|
| 13 |
Could routine race-adjustment of spirometers exacerbate racial disparities in COVID-19 recovery?
|
Anderson, Meredith A
|
|
|
9 |
2 |
p. 124-125
|
artikel
|
| 14 |
COVID-19: the lessons learned amongst the losses
|
Szekely, Megan
|
|
|
9 |
2 |
p. 134-135
|
artikel
|
| 15 |
180 degree shift
|
Nolan, Adam
|
|
|
9 |
2 |
p. 132-134
|
artikel
|
| 16 |
Effect of a single day of increased as-needed budesonide–formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
|
O'Byrne, Paul M
|
|
|
9 |
2 |
p. 149-158
|
artikel
|
| 17 |
Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial
|
Eisen, Damon P
|
|
|
9 |
2 |
p. 186-195
|
artikel
|
| 18 |
Herd immunity for COVID-19
|
Burki, Talha Khan
|
|
|
9 |
2 |
p. 135-136
|
artikel
|
| 19 |
Living with idiopathic pulmonary fibrosis
|
Kirby, Tony
|
|
|
9 |
2 |
p. 136-138
|
artikel
|
| 20 |
Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial
|
Vento, Giovanni
|
|
|
9 |
2 |
p. 159-166
|
artikel
|
| 21 |
National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study
|
Li, You
|
|
|
9 |
2 |
p. 175-185
|
artikel
|
| 22 |
Nebulised interferon beta-1a for patients with COVID-19
|
Peiffer-Smadja, Nathan
|
|
|
9 |
2 |
p. 122-123
|
artikel
|
| 23 |
New reference atlas for pulmonary fibrosis severity score in systemic sclerosis
|
Williamson, Lucy
|
|
|
9 |
2 |
p. 130-131
|
artikel
|
| 24 |
New variant of SARS-CoV-2 in UK causes surge of COVID-19
|
Kirby, Tony
|
|
|
9 |
2 |
p. e20-e21
|
artikel
|
| 25 |
NICE guideline on long COVID
|
Venkatesan, Priya
|
|
|
9 |
2 |
p. 129
|
artikel
|
| 26 |
Pandemic thoughts from a British junior doctor in Melbourne
|
Moini, Nasreen
|
|
|
9 |
2 |
p. 131-132
|
artikel
|
| 27 |
Realising the potential of SARS-CoV-2 vaccines—a long shot?
|
The Lancet Respiratory Medicine,
|
|
|
9 |
2 |
p. 117
|
artikel
|
| 28 |
Recruitment: the best way to IN-SUR-E surfactant delivery?
|
Finer, Neil N
|
|
|
9 |
2 |
p. 119-120
|
artikel
|
| 29 |
Remdesivir for COVID-19 in Europe: will it provide value for money?
|
Dal-Ré, Rafael
|
|
|
9 |
2 |
p. 127-128
|
artikel
|
| 30 |
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
|
Monk, Phillip D
|
|
|
9 |
2 |
p. 196-206
|
artikel
|
| 31 |
Small airway loss in the physiologically ageing lung: a cross-sectional study in unused donor lungs
|
Verleden, Stijn E
|
|
|
9 |
2 |
p. 167-174
|
artikel
|
| 32 |
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
|
Botta, Michela
|
|
|
9 |
2 |
p. 139-148
|
artikel
|
Tijdschrift beschrijving